MicroRNAs (miRNAs) play critical roles in a broad variety of biological processes by inhibiting translation initiation and by destabilizing target mRNAs. The CCR4-NOT complex effects miRNA-mediated silencing at least in part through interactions with 4E-T (eIF4E-Transporter) protein, but the precise mechanism is unknown. Here we show that the cap-binding eIF4E-Homologous Protein 4EHP is an integral component of the miRNA-mediated silencing machinery. We demonstrate that the cap-binding activity of 4EHP contributes to the translational silencing by miRNAs through the CCR4-NOT complex. Our results suggest that 4EHP competes over eIF4E for binding to 4E-T, and this interaction increases the affinity of 4EHP for the cap. We propose a model wherein the 4E-T/4EHP interaction triggers the assembly of a closed loop mRNA conformation that blocks translational initiation of miRNA targets. facilitates the formation of a closed-loop structure between the 3´ UTR of the mRNA and its 5´cap, which causes repression of mRNA translation.
Statement of significance
miRNAs are important components of gene regulatory networks and affect virtually all aspects of cell biology by controlling the stability and translation efficiency of their target mRNAs. Here we identified the mRNA cap-binding eIF4E-related protein, 4EHP as an effector of miRNA-mediated translation repression. Through screening for protein interactions in cells via the BioID method, we identified 4EHP as a component of the CCR4-NOT/DDX6/4E-T axis. Direct interaction between 4E-T and 4EHP increases the latter's cap-binding affinity, suggesting that this interaction potentiates its competition with the eIF4F complex for binding to the mRNA 5´cap. Our findings suggest that 4EHP
facilitates the formation of a closed-loop structure between the 3´ UTR of the mRNA and its 5´cap, which causes repression of mRNA translation.
INTRODUCTION
MicroRNAs (miRNAs) are short ∼22-nucleotide noncoding RNAs that affect gene expression in most eukaryotes. miRNAs mediate post-transcriptional silencing by guiding the miRNA-induced silencing complex (miRISC), an assembly of Argonautes and GW182/TNRC6 proteins, to target mRNAs. Target recognition initiates a succession of events: mRNA translational repression, deadenylation and mRNA decay (1). miRNAs impair the function of eIF4F on mRNAs, a three-subunit complex composed of eIF4E, the m 7 GTP (cap)-interacting factor, eIF4G, a scaffolding protein, and eIF4A, a DEADbox RNA helicase (2) (3) (4) (5) . The silencing activity of miRISC is mediated by the CCR4-NOT deadenylase complex through the scaffolding subunit, CNOT1 (6) (7) (8) . CNOT1
recruits the DDX6 and 4E-T (eIF4E-Transporter) proteins and their interaction is important for miRNA-mediated silencing (9) (10) (11) (12) (13) (14) (15) (16) . 4E-T is a conserved eIF4E-binding protein, which directly binds to the dorsal surface of eIF4E through its canonical eIF4E-binding YX4LL (Y 30 TKEELL) motif, and impairs the eIF4E/eIF4G interaction and translation initiation (17) . 4E-T also facilitates the decay of CCR4-NOT targeted mRNAs by linking the 3'-terminal mRNA decay machinery to the cap via its interaction with eIF4E (13) .
In mammals, eIF4E is the best-studied member of a family of proteins composed of eIF4E (eIF4E1), 4EHP (4E-Homologous Protein; eIF4E2) and eIF4E3. 4EHP and eIF4E3
share respectively 28% and 25% sequence identity with eIF4E (18, 19) . 4EHP is a ubiquitously expressed protein, and it is 5-10 times less abundant than eIF4E in a number of mammalian cell lines (18) (19) (20) . Like eIF4E, 4EHP binds to 4E-T, but in contrast, it does not associate with eIF4G (18, 21) . 4EHP has a 30-100-fold weaker affinity for the cap than eIF4E due to a two amino acid substitution in its cap-binding pocket (22) . However, post-translational modifications can improve 4EHP affinity for the cap (23, 24) .
4EHP has primarily been studied as a translation repressor. In the Drosophila embryo, 4EHP associates with the RNA binding protein Bicoid to repress caudal mRNA translation (25) . Similarly, 4EHP also represses the hunchback mRNA via its interaction with the nanos repressive element (NRE) complex, which consists of nanos, pumilio, and "brain tumor" proteins (26) . A similar mechanism functions in mouse, where 4EHP binds the Prep1 RNA-binding protein and inhibits Hoxb4 mRNA translation (27) . Moreover, 4EHP forms a translational repressor complex with GIGYF2 (Grb10-interacting GYF protein 2), which acts as a cofactor in translational repression and mRNA decay of tristetraprolin-targeted mRNAs (28, 29) .
In this study, we demonstrate that 4EHP interacts with the mRNA silencing machinery, and engenders miRNA-mediated translational repression. Our data support a model wherein 4EHP interactions with miRISC/CCR4-NOT lead to the translational repression of miRNA targets.
RESULTS

4EHP is a component of the miRISC effector machinery.
The specificity of eIF4E and 4EHP for their mRNA targets and their affinities for the cap are defined by binding partners (2, 28, 30) . Thus, we utilized the BioID assay (31) to identify the eIF4E and 4EHP interacting proteins. We created stable cell lines expressing 4EHP or eIF4E fused in-frame with an abortive biotin ligase BirA* (R118G) (Fig. S1A and B). 4EHP and eIF4E proteins were thus used as baits to biotinylate and capture interactors and proteins in close proximity. Biotinylated proteins were isolated using streptavidin-affinity purification under denaturing conditions and analyzed by mass spectrometry (MS). Each bait protein was fused at its N-or C-terminus to BirA* and two independent replicates for each construct were analyzed (4 in total for each bait protein), alongside negative controls. The MS data were processed with the SAINT (Significance Analysis of INTeractome) computational tool (32) using several controls for statistical analysis to assign confidence scores to interaction pairs (Dataset S1; see Materials and Methods). Data were highly consistent across replicates (mean correlation coefficient FLAG-tagged 4EHP co-precipitated 4E-T and the CNOT1 subunit of the CCR4-NOT complex (Fig. 1C) . Likewise, endogenous 4EHP co-precipitated with endogenous DDX6, as well as HA-tagged PATL-1, a physical partner of both CCR4-NOT, DDX6 and 4E-T (12, 34, 35) ( Fig. 1D and E) . Taken together, these data demonstrate that 4EHP
physically associates with several key proteins involved in miRISC/CCR4-NOTmediated gene silencing.
4EHP effects miRNA-dependent translational repression.
The association of 4EHP with components of miRISC and its effector machinery (CCR4-NOT, 4E-T, DDX6) raised the possibility that 4EHP plays a role in miRNA-mediated silencing. To investigate this, we used a luciferase construct ( Fig. 2A) Similarly, siRNA knockdown of 4E-T partially relieved the repression exerted by tethered CNOT1 (1.8-fold vs 2.9-fold repression in siCTR) ( Fig. S2H and I ). We also examined the role of 4EHP on the repressive activity of the C-terminal silencing domain of human GW182/TNRC6C (GW182(SD); AA 1382-1690), which functions through CNOT1 recruitment (6) (7) (8) . Consistent with the effects on the miRNA reporters and with the CNOT1 tethering experiment, 4EHP-depletion impinged on the repression exerted by tethered GW182(SD) (1.8-fold de-repression) ( Fig. 2E and S2G ).
We next examined the importance of the cap-binding activity of 4EHP for miRNAmediated silencing. We performed a complementation assay using tethered λN-CNOT1
in the presence of WT 4EHP or the 4EHP W124A mutant, which is incapable of binding to the cap (19) . Transient transfection of shRNA-resistant 3xFlag-4EHP in 4EHP-knockdown cells restored λN-CNOT1-mediated translation repression ( Fig. 2F and S2J ), while transfection with 4EHP W124A did not. These results demonstrate that cap binding by 4EHP is required for translation repression effected through CCR4-NOT.
4EHP and eIF4E compete for binding to 4E-T.
4E-T is enriched among 4EHP BioID targets (Fig. 1A) , but 4E-T also interacts with eIF4E, and both eIF4E and 4EHP bind the same eIF4E-binding motif of 4E-T (Y 30 TKEELL) (21) . We compared the effects of mutations in this motif on the interactions of 4E-T with 4EHP and eIF4E. We co-transfected HEK293T cells with constructs encoding 3xFlag-4EHP and either WT HA-tagged 4E-T, or 4E-T bearing point mutations in the YTKEELL motif (Y 30 A and 4A; YTKEELLAAKEEAA) and tested their interactions by IP. 4E-T co-immunoprecipitated with 4EHP and eIF4E, but both interactions were lost with either mutants of the YTKEELL motif (Fig. 3A) . It is noteworthy that wild-type HA-4E-T immunoprecipitated a greater portion of 3xFlag-4EHP, relative to the amount of input, compared with endogenous eIF4E. We thus hypothesized that 4E-T may bind better to 4EHP than to eIF4E (Fig. 3A) . To further study this difference, we performed an IP assay in transfected HEK293T cells, which coexpressed constant amounts of HA-4E-T, and incremental amounts of Flag-4EHP (Fig.   3B ). While the interaction between HA-4E-T and endogenous eIF4E could be detected in the absence of exogenous 4EHP, overexpression of 4EHP prevented 4E-T binding to eIF4E (Fig. 3B) . To further examine these interactions, we prepared recombinant 4EHP, eIF4E and 4E-T proteins and performed in vitro binding assays. We compared the 4E-T/4EHP and 4E-T/eIF4E interactions in vitro by using constant amounts of HA-4E-T and increasing concentrations of His-4EHP or His-eIF4E ( Fig. S3A and B) . In such conditions, 4EHP was 20-30 times more potent than eIF4E for binding to 4E-T ( Fig. 3C;   Fig. S3C ). To corroborate the preference of 4E-T for 4EHP over eIF4E, we performed an in vitro displacement assay using pre-associated HA-4E-T/eIF4E immobilized on anti-HA agarose beads. An excess amount of eIF4E was incubated with the 4E-T-bound beads to saturate the binding sites on 4E-T. Preassembled eIF4E/4E-T complexes were next incubated with increasing amounts of recombinant 4EHP. In such conditions, addition of 1.8 µM of 4EHP displaced more than 60% of eIF4E bound to 4E-T (Fig. 3D ). Altogether these results suggest that 4EHP has a competitive advantage over eIF4E for binding to 4E-T.
4E-T interaction increases the affinity of 4EHP to m 7 GTP cap.
Protein interaction and post-translational modifications can significantly modulate the affinity of eIF4E and 4EHP for the cap (23, 24, 40) . In addition to the canonical YTKEELL motif, both 4EHP and eIF4E interact with a secondary non-canonical sequence of 4E-T. However, the contribution of the non-canonical motif appears more important for interaction with 4EHP (21). We thus hypothesized that the extended interaction surface of 4E-T and its greater affinity for 4EHP (Fig. 3 ) may influence the ability of 4EHP to bind the m 7 GTP cap. To test this, we performed an Isothermal Titration Calorimetry (ITC) assay to examine how interaction with 4E-T polypeptides impacted 4EHP affinity for the cap. We used three different 4E-T peptides: one encoding the canonical YTKEELL motif alone (4E-T 28-37 ; Fig. S4A ), the same sequence in combination with the non-canonical motif (4E-T 28-71 ), and another, which covers the entire N-terminal extremity (4E-T 1-265 , Fig. S4A ). The 4E-T peptides were pre-incubated with recombinant 4EHP protein and titrated with m 7 GTP. Using this assay, the affinity of 4EHP for m 7 GTP was 8.0 ± 0.56x10 -6 M in the absence of 4E-T peptides (Table 1 and Fig. S4B ). Adding the 4E-T 28-37 peptide did not significant change this affinity. However, the affinity of 4EHP for the m 7 GTP cap was 4-fold greater in the presence of the Nterminus of 4E-T (KD of 5.9 ± 0.7x10 -6 M and 1.8 ± 0.4x10 -6 M for 4E-T 28-71 and 4E-T 1-265 , respectively; Table 1 and Fig. S4B-E) . In comparison, the affinity of eIF4E for the m 7 GTP cap (KD 8.8 ± 11x10 -8 M) remained virtually unchanged by the 4E-T peptides (Table 1 and Fig. S4F-I ). Altogether, these results suggest that 4E-T interactions with 4EHP enhance its binding to the m 7 GTP cap structure.
DISCUSSION
Here, we describe a role for 4EHP in miRNA-mediated translation repression. Our results suggest that miRISC recruits 4EHP to target mRNAs through the CCR4-NOT complex.
We propose that these interactions engender a closed-loop mRNP structure (Fig. 4) , which resembles the cap-to-tail closed-loop mRNA conformation in translation initiation (41) . A similar mechanism of translational inhibition had been described in Drosophila embryos wherein an interaction between d4EHP and Bicoid bridges the 5′ and 3′ ends of caudal mRNA (25) . Thus, 4EHP-mediated mRNA looping appears as a general repressive mechanism implicated in various post-transcriptional regulatory pathways.
This mechanism can also be employed by other RNA-binding proteins such as pumilio family members, tristetraprolin and nanos, which recruit CCR4-NOT to mRNAs (42) .
An additional layer of complexity in understanding the exact mechanism of 4EHP action stems from the interaction of 4EHP with other protein partners. For instance, the GIGYF1/2 and 4E-T proteins bind to the same 4E-T binding motif on the 4EHP protein, and thus likely compete with 4E-T for this binding site. The GIGYF1/2-4EHP complex had been characterized as a translational repressor, notably as a cofactor of tristetraprolin (28, 29) . Interestingly, GIGYF1/2 also associate with CCR4-NOT in both yeast and human cells (43, 44) . Furthermore it was reported that GIGYF2 co-immunoprecipitates with AGO2, and tethering of GIGYF2 to a mRNA leads to its silencing (45) . Therefore, it is conceivable that the miRISC/CCR4-NOT axis may recruit 4EHP via several parallel interactions, namely through interactions with both GIGYF1/2 and 4E-T.
Our model provides a tenable model of miRNA-mediated translation repression, but further investigation is necessary to fully resolve the interactions that occur at the cap of miRNA targets. An important conundrum is that the affinity of recombinant eIF4E for the cap is 30-100-fold greater than that of recombinant 4EHP. While binding to 4E-T increases 4EHP's affinity for the cap by ~4-fold, it remains much weaker than eIF4E
( Fig. S4 and Table 1 ). The solution to this discrepancy may lie in additional interactions that prevail within the native miRISC effector complex and are missing from in vitro assays. Other interactions may further improve the affinity of 4EHP for the cap. Further study of the protein-protein interactions identified in our BioID survey may help resolve this conundrum. Alternatively, since the affinity of 4E-T for 4EHP is greater than that for eIF4E it is also possible that their interaction may enhance the proximal concentration of 4EHP near the cap to potentiate competition with eIF4E.
It was recently reported that 4E-T is recruited to mRNAs targeted by CCR4-NOT, and
functions as an important co-factor of the mRNA decay machinery (13) . This raises the intriguing possibility that 4E-T plays a dual role in miRNA-mediated silencing: 4E-T interactions with 4EHP potentiate translation repression, while its direct binding to eIF4E enables mRNA decay. Therefore, it would be interesting to determine the relative importance of eIF4E/4E-T versus 4EHP/4E-T contributions under different circumstances to miRNA action.
While significant progress had been made in understanding how they instigate mRNA deadenylation and decay, the mechanisms by which miRNAs repress translation remained unclear (1). Several recent studies demonstrated translational repression as an early step of miRNA-mediated silencing, which is followed by mRNA deadenylation and decay (4, 46, 47) . Multiple studies now have shown that miRNAs interfere with translation initiation, specifically with cap recognition by eIF4E (3) (4) (5) , and may induce the dissociation of eIF4E and eIF4G from target mRNAs (48) . The model outlined here wherein 4E-T/4EHP interactions potentiate an interaction with the cap shines a new light on those prior findings.
Materials and Methods
BioID; Affinity purification (AP) and Trypsin digestion
For BioID experiments, stable cells were grown to ~75% confluency. Bait expression vectors and biotin were induced simultaneously (1 µg/ml tetracycline, 50 µM biotin).
After 24 h of treatment, cells were rinsed once on the plate with ~20 ml PBS, then 
Mass spectrometry (MS)
Dried peptides were resuspended in 10 µL of 2% formic acid, and 1. in presence of 4E-T peptides, as determined by Isothermal Titration Calorimetry (ITC).
See Fig. S4A for a schematic description of the peptides. 
